The pharmacovigilance market is growing rapidly due to the increasing number of adverse drug reactions (ADRs) and stricter regulatory requirements for ensuring drug safety, Says SNS Insider.
“According to SNS Insider Research, The Pharmacovigilance Market size was valued at US$ 7.20 billion in 2023, and estimated to reach US$ 18.52 billion by 2032 with CAGR of 11.09% over the forecast period 2024-2032.”